首页> 外文OA文献 >Non-prescribed use of psychoactive prescription drugs among drug-impaired drivers in Sweden
【2h】

Non-prescribed use of psychoactive prescription drugs among drug-impaired drivers in Sweden

机译:瑞典毒品受损驾驶员中非处方使用精神活性处方药

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Aims: To determine the prevalence of non-prescribed drug use among subjects suspected of drug impaired driving with a psychoactive prescription drug, and to identify associated factors. Methods: Subjects investigated for drug-impaired driving in Sweden during 2006-2009 with a confirmed intake of diazepam, flunitrazepam, tramadol, zolpidem or zopiclone were identified using the Swedish Forensic Toxicology Database. Information on dispensed prescription drugs was retrieved from the Swedish Prescribed Drug Register. Non-prescribed use was our outcome, defined as a psychoactive prescription drug intake confirmed by toxicological analysis in a subject by whom it was not dispensed in the 12 months preceding the sampling. Prevalence proportions were calculated for each drug and logistic regression was used to identify associated factors. Results: In total, 2225 subjects were included. The median age (range) was 34 (15-80) years and 1864 (83.8%) subjects were male. Non-prescribed use was found in 1513 subjects (58.7%); for flunitrazepam 103 (76.3%), diazepam 1098 (74.1%), tramadol 192 (40.3%), zopiclone 60 (29.7%), and zolpidem 60 (21.2%) subjects, respectively. Younger age and multiple-substance use were associated with non-prescribed use, whereas ongoing treatment with other psychoactive drugs was negatively associated with non prescribed use. Conclusions: Non-prescribed use of psychoactive prescription drugs was common in subjects suspected of drug-impaired driving and was more frequent for benzodiazepines and tramadol compared to zolpidem and zopiclone. The young and multi-substance users were more likely, whereas subjects with ongoing prescribed treatment with other psychoactive drugs were less likely, to use non-prescribed drugs.
机译:目的:确定在怀疑使用精神活性处方药驾驶的药物受损受试者中非处方药使用的普遍性,并确定相关因素。方法:使用瑞典法医毒理学数据库确定2006-2009年期间瑞典确诊摄入地西epa,氟硝西epa,曲马多,唑吡坦或佐匹克隆的药物受损驾驶者。从瑞典处方药注册处检索到有关处方药的信息。非处方使用是我们的结果,定义为通过毒理学分析确认的受试者在采样前12个月内未分配的精神活性处方药。计算每种药物的患病率,并使用逻辑回归确定相关因素。结果:总共包括2225名受试者。中位年龄(范围)为34(15-80)岁,其中1864名(83.8%)为男性。在1513名受试者中发现了非处方用途(58.7%);分别为氟硝西epa 103(76.3%),地西epa 1098(74.1%),曲马多192(40.3%),佐匹克隆60(29.7%)和唑吡坦60(21.2%)受试者。较年轻的年龄和多种药物的使用与非处方药相关,而正在进行的其他精神活性药物治疗与非处方药呈负相关。结论:在怀疑患有药物驾驶障碍的受试者中,非处方使用精神活性处方药很普遍,与唑吡坦和佐匹克隆相比,苯二氮卓类和曲马多的使用频率更高。年轻人和多物质使用者更有可能使用非精神药物进行正在进行的使用其他精神药物进行处方治疗的受试者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号